Table 1 Pros and cons of making patients and their families responsible
From: Who should pay for the continuity of post-trial health care treatments?
Patients and Families | |
|---|---|
Pros | Cons |
Reduce the final cost of medicines | Could limit the access of low-income persons / families |
Make the conduction of clinical trials more attractive to sponsors | |
Can make patients and families more compliant to treatment | |